Molecular effects of bioactive fraction of Curcuma mangga (DLBS4847) as a downregulator of 5α-reductase activity pathways in prostatic epithelial cells

References

• PennaBFibbiBAmuchasteguiSHuman benign prostatic hyperplasia stromal cells as inducers and targets of chronic immuno-mediated inflammationJ Immunol200918274056406419299703
   PubMed Web of Science ®Google Scholar
• BeckmanTJMynderseLAEvaluation and medical management of benign prostatic hyperplasiaMayo Clin Proc200580101356136216212149
   PubMed Web of Science ®Google Scholar
• FineARGinsbergPAlpha-adrenergic receptor antagonists in older patients with benign prostatic hyperplasia: issues and potential complicationsJ Am Osteopath Assoc2008108733333718648026
   PubMedGoogle Scholar
• MostaghelEAGengLHolcombIVariability in the androgen response of prostate epithelium to 5α-reductase inhibition: Implications for prostate cancer chemopreventionCancer Res20107041286129520124490
   PubMed Web of Science ®Google Scholar
• DasKLorenaPDShenLDifferential expression of steroid 5α-reductase isozymes and association with disease severity and angiogenic genes predict their biological role in prostate cancerEndocr Relat Cancer201217375777020519274
   PubMed Web of Science ®Google Scholar
• GrossmannMEHuangHTindallDJAndrogen receptor signaling in androgen-refractory prostate cancerJ Natl Cancer Inst200193221687169711717329
   PubMed Web of Science ®Google Scholar
• LamontKRTindallDJMinireview: Alternative activation pathways for the androgen receptor in prostate cancerMol Endrocinol2011256897907
   Web of Science ®Google Scholar
• HaSRuoffRKahoudNFrankeTFLoganSKAndrogen receptor levels are upregulated by Akt in prostate cancerEndocr Relat Cancer201118224525521317204
   PubMed Web of Science ®Google Scholar
• SciarraAMariottiGSalcicciaSProstate growth and inflammationJ Steroid Biochem Mol Biol20081083–525426017935971
   PubMed Web of Science ®Google Scholar
• TrisinaJSunardiFSuhartonoMTTjandrawinataRRDLBS1033, a protein extract from Lumbricus rubellus, possesses antithrombotic and thrombolytic activitiesJ Biomed Biotech20112011519652
   Google Scholar
• TjandrawinataRRNofiarnyDSutantoLHendriPClarissaASymptomatic treatment of premenstrual syndrome and/or primary dysmenorrhea with DLBS1442, a bioactive extract of Phaleria macrocarpaInt J Gen Med2011446547621760747
   PubMedGoogle Scholar
• TjandrawinataRRArifinPFTandrasasmitaOMRahmiDAripinADLBS1425, a Phaleria macrocarpa (Scheff.) Boerl extract confers anti proliferative and proapoptosis effects via eicosanoid pathwayJ Exp Ther Oncol20108318720120734918
   PubMedGoogle Scholar
• TandrasasmitaOMLeeJSBaekSHTjandrawinataRRInduction of cellular apoptosis in human breast cancer by DLBS1425, a Phaleria macrocarpa compound extract, via down-regulation of PI3-kinase/AKT pathwayCancer Biol Ther201010881482320703095
   PubMed Web of Science ®Google Scholar
• TjandrawinataRRNailufarFArifinPFHydrogen potassium adenosine triphosphatase activity inhibition and downregulation of its expression by bioactive fraction DLBS2411 from Cinnamomum burmanii in gastric parietal cellsInt J Gen Med20132013680781524101879
   PubMedGoogle Scholar
• TandrasasmitaOMWulanDDNailufarFSinambelaJTjandrawinataRRGlucose-lowering effect of DLBS3233 is mediated through phosphorylation of tyrosine and upregulation of PPARγ and GLUT4 expressionInt J Gen Med20112011434535721674027
   PubMedGoogle Scholar
• FagelmanELoweFCSaw palmetto berry as a treatment for BPHRev Urol20013313413816985705
   PubMedGoogle Scholar
• GjertsonCJWalmsleyKKaplanSABenign prostatic hyperplasia: now we can begin to tailor treatmentCleve Clin J Med2004711185788015570735
   PubMed Web of Science ®Google Scholar
• YamanishiTYasudaKKamaiTSingle-blind, randomized controlled study of the clinical and urodynamic effects of an α-blocker (naftopidil) and phytotherapy (eviprostat) in the treatment of benign prostatic hyperplasiaInt J Urol200411750150915242359
   PubMed Web of Science ®Google Scholar
• BaumanDRSteckelbroeckSPeehlDMPenningTMTranscript profiling of the androgen signal in normal prostate, benign prostatic hyperplasia, and prostate cancerEndrocinology20061471258065816
   Web of Science ®Google Scholar
• SöderströmTGBjelfmanCBrekkanEMessenger ribonucleic acid levels of steroid 5-alpha-reductase-2 in human prostate predict the enzyme activityJ Clin Endrocinol Metab2001862855858
   Web of Science ®Google Scholar
• ZhuYSCaiLQYouXCorderoJJHuangYImperato-McginleyJAndrogen-induced prostate-specific antigen gene expression is mediated via dihydrotestosterone in LNCaP cellsJ Androl200324568168712954658
   PubMed Web of Science ®Google Scholar
• SchmidtLJMurilloHTindallDT2004. Gene expression in prostate cancer cells treated with the dual 5 alpha-reductase inhibitor dutasterideJ Androl200425694495315477368
   PubMedGoogle Scholar
• SmithCMBallardSAWormanNBuettnerRMastersJR5α-Reductase expression by prostate cancer cell lines and benign prostatic hyperplasia in vitroJ Clin Endocrinol Metab1996814136113668636334
   PubMed Web of Science ®Google Scholar
• HamiltonRJKahwatiLCKinsingerLSKnowledge and use of finasteride for the prevention of prostate cancerCancer Epidemiol Biomarkers Prev20101992164217120699373
   PubMed Web of Science ®Google Scholar
• AkazaHKanetakeHTsukamotoTEfficacy and safety of dutasteride on prostate cancer risk reduction in Asian men: the results from the REDUCE studyJpn J Clin Oncol201141341742321123311
   PubMed Web of Science ®Google Scholar
• SvatekRSLotanYCost utility of prostate cancer chemoprevention with dutasteride in men with an elevated prostate specific antigenCancer Prev Res (Phila)20114227728321163937
   PubMed Web of Science ®Google Scholar
• PapatsorisAGKaramouzisMVPapavassilouAGThe power and promise of “rewiring” the mitogen-activated protein kinase network in prostate cancer therapeuticsMol Cancer Ther20076381181917363478
   PubMed Web of Science ®Google Scholar
• GhoshRGrahamHRivasPPhellodendron amurense bark extract prevents progression of prostate tumors in transgenic adenocarcinoma of mouse prostate: potential for prostate cancer managementAnticancer Res201030385786520393007
   PubMed Web of Science ®Google Scholar
• DeebDJiangHGaoXCurcumin sensitizes prostate cancer cells to tumor necrosis factor-related apoptosis-inducing ligand/Apo2L by inhibiting nuclear factor-κB through suppression of IκBα phosphorylationMol Cancer Ther20043780381215252141
   PubMed Web of Science ®Google Scholar